Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TEAD inhibitors(TEA domain transcription factors inhibitors), YAP1 inhibitors(Yes1 associated transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization TYK Medicines, Inc.Startup |
Active Organization TYK Medicines, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Preclinical | CN | TYK Medicines, Inc.Startup | 18 Apr 2023 |
Mesothelioma | Preclinical | CN | TYK Medicines, Inc.Startup | 18 Apr 2023 |
Non-Small Cell Lung Cancer | Preclinical | CN | TYK Medicines, Inc.Startup | 18 Apr 2023 |